Male C57BL/6J mice (4 months old) were assigned to ground control or hindlimb unloading (HU) groups under normoxia (21% O 2) or hypoxia (15% O 2) and treated daily with placebo or resveratrol (20 or ...

As people age, muscles naturally lose mass and strength, a condition known as sarcopenia. The decline can make everyday activities harder and increases the risk of falls, disability, and early death.

Before Adam Sharples became a molecular physiologist studying muscle memory, he played professional rugby. Over his years as an athlete, he noticed that he and his teammates seemed to return to form ...

Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could transform treatment for one of cancer's most devastating complications.

This video breaks down my complete weekly diet plan for building muscle while staying lean. I’ll take you step by step through my meal prep routine, the exact foods I eat, and how I balance nutrition ...

Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly due to underlying medical conditions. Other factors can contribute, like ...

Muscle wasting is a continuum of diseases that entail incremental skeletal muscle mass, as well as functionality, loss and is an important cause of morbidity, mortality, as well as quality of life ...

The more we move, the more our muscle cells begin to make a memory of that exercise. MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you ...

GLD Partners has secured access to Heligenics’ GigaAssay platform to launch Altagenics, a startup with ambitions to develop first-in-class medicines for muscle-wasting conditions. Altagenics will use ...

Introduction: We have previously shown that angiotensin II (Ang II) type 2 receptor (AT2R) positively regulates skeletal myoblast differentiation. Systemic angiotensin II (Ang II) increase or ...

While the prevalence of sarcopenia is low among patients with ankylosing spondylitis (8.66%), a significant percentage still experience muscle atrophy. While sarcopenia is relatively uncommon in ...